Dyne Therapeutics 40% Rally Faces Fund Selloff Questions
A dramatic 40% jump for Dyne Therapeutics has investors watching closely as a biotech-focused fund disclosed a sizabl...
Find out which credit cards offer the best rewards in the market. Make an informed choice and start maximizing your benefits.
13,280 articlesA dramatic 40% jump for Dyne Therapeutics has investors watching closely as a biotech-focused fund disclosed a sizabl...
During 13F season, big investors reveal shifts in their portfolios. This piece explains the move, why Microsoft was f...
As market rates swing and volatility persists, a 4.75% yield from an active covered-call ETF is reshaping retirement ...
A dramatic one-day move put Relay Therapeutics in the spotlight. After encouraging Phase 2 results for zovegalisib an...
As market focus shifts away from growth labels, three legacy automakers stand out for retirees seeking cash flow and ...
XRP has shed roughly 44% over the past year, prompting renewed debate about a rebound. Analysts point to regulatory c...
Three leading space names moved higher in a risk-on trading session, with AST SpaceMobile, Rocket Lab and Planet Labs...
As markets wobble in 2026, wealthy retirees are accelerating Roth conversions to minimize taxes and control when inco...
At age 60, a saver funds an adult child’s family to the tune of hundreds of thousands annually, risking retirement. T...
As Kevin Warsh takes the helm at the Federal Reserve, XRP and the Ripple ecosystem face a fresh policy backdrop. Gemi...
A leading investing author known for the stock market maestros concept argues that enduring gains come from disciplin...
Lemonade is betting big on AI to transform how people buy insurance and file claims. This article digs into what lemo...